Reference
Nakano M, et al. Efficacy of BRAF inhibitor and anti-EGFR antibody in colorectal neuroendocrine carcinoma. Clinical Journal of Gastroenterology 15: 413-418, No. 2, Apr 2022. Available from: URL: http://www.springer.com/medicine/internal/journal/12328?cm_mmc=AD-_-FTA-_-CLM1805-_-0
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1911, 43 (2022). https://doi.org/10.1007/s40278-022-17340-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-17340-8